Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 18, 2022

SELL
$94.08 - $130.2 $41,018 - $56,767
-436 Closed
0 $0
Q4 2021

Jan 31, 2022

SELL
$129.87 - $162.82 $1,558 - $1,953
-12 Reduced 2.68%
436 $234,000
Q3 2021

Oct 13, 2021

BUY
$106.71 - $143.18 $47,806 - $64,144
448 New
448 $245,000
Q1 2021

Apr 12, 2021

SELL
$84.79 - $104.74 $61,557 - $76,041
-726 Closed
0 $0
Q4 2020

Feb 08, 2021

BUY
$78.0 - $104.5 $4,758 - $6,374
61 Added 9.17%
726 $268,000
Q3 2020

Oct 15, 2020

BUY
$95.51 - $112.95 $63,514 - $75,111
665 New
665 $274,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $25.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Teamwork Financial Advisors, LLC Portfolio

Follow Teamwork Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teamwork Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Teamwork Financial Advisors, LLC with notifications on news.